China Pharma Holdings (CHPI) Return on Equity ROE from the second quarter 2012 to second quarter 2011 and annually, average high and low, overall ranking from Jun 30 2012 to Jun 30 2011 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
China Pharma Holdings, Inc.  (CHPI)

China Pharma Holdings's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for China Pharma Holdings in the second quarter 2012?
China Pharma Holdings, Inc. achieved a return on average equity (ROE) of 15.77 % in its second quarter 2012 a new company high.

ROE decreased relative to the period ending , due to the decline in net income.

Within the Major Pharmaceutical Preparations industry 31 other companies had a higher return on equity. While the total ranking for ROE unchanged, relative to the first quarter 2012 at no. .

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Jun 30 2012)
II. Quarter		 (Mar 31 2012)
I. Quarter		 (Dec 31 2011)
IV. Quarter		 (Sep 30 2011)
III. Quarter		 (Jun 30 2011)
II. Quarter
Y / Y Equity Change 21.06 % 65.58 % - - -
Y / Y Net Income Change - 14.31 % -39.82 % 3.76 % -
Net Income (TTM) in Millions 1 2 2 3 3
Return On Equity (TTM) 15.77 % 32.79 % 35.64 % 55.27 % 88.93 %
CHPI's Total Ranking # # # # #
Equity (TTM) in Millions 8 8 7 7 6
Seq. Equity Change -4.34 % 9.19 % 5.64 % 9.71 % 30.84 %
Seq. Net Income Change - 76.92 % -34.96 % -33.07 % 48.41 %

Back to CHPI Management Effectiveness >> CHPI's 5 Years Annual ROE >> Compare CHPI ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 32
Sector # 87
Overall #

Return On Equity Statistics
High Average Low
15.77 %
15.77 %
15.77 %
(Jun 30 2012)  





CHPI Annual Return On Equity (Dec 31 2010)
2011



Total Equity in Millions 5 0 0 0 0
Y / Y Equity Change - - - - -
Net Income in Millions 2 0 0 0 0
Y / Y Net Income Change - - - - -
Return On Equity 35.25 % - - - -

Back to CHPI Management Effectiveness >> CHPI's 5 Years Annual ROE >> Compare CHPI ROE to its Competitors




Annual Roe Comment
In 2011 ROE improved to 35.25 % compared to the previous year, due to net income growth.


More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
CHPI's' Return on Equity at Yahoo Finance
CHPI's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for CHPI's Competitors
Subscribers only: Roe for China Pharma Holdings's Suppliers
Subscribers only: Return On Equity for CHPI's Customers




Companies with similar Return On Equity at Jun 30 2012, within Healthcare Sector ROE
Spectrum Pharmaceuticals Inc   43.13 %
Veru Inc   42.73 %
Gilead Sciences Inc   35.63 %
Mettler toledo International Inc   35.25 %
Waters Corporation  34.43 %
Baxter International Inc   33.99 %
Option Care Health Inc   32.78 %
Idexx Laboratories Inc  31.83 %
Neurocrine Biosciences Inc   30.83 %
United Therapeutics Corporation  28.76 %
Eli Lilly And Company  27.92 %
Bard C R Inc  27.83 %
Varian Medical Systems Inc   27.30 %
Celgene Corp  27.02 %
3m Company  25.96 %
Jazz Pharmaceuticals Plc  25.63 %
Becton Dickinson And Company  25.51 %
Bristol myers Squibb Company  24.33 %
U S Physical Therapy Inc  24.25 %
Davita Inc   24.24 %
Labcorp Holdings Inc   22.88 %
Meridian Bioscience Inc   22.59 %
Medicines Co  22.17 %
Agilent Technologies inc   22.11 %
Utah Medical Products Inc  22.08 %
Nature s Sunshine Products inc   21.72 %
Medtronic Plc  21.45 %
Biogen Inc   21.27 %
Intuitive Surgical Inc   20.57 %
Allergan plc  19.80 %

Date modified: 2026-09-02T20:25:00+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.